Fluctuating Capacity and Demand Conditions in Biomanufacturing

BioPharm International

eBooks Volume 28, Issue 14  

Contract manufacturing is a booming business, especially considering that many pharmaceutical companies-including those with a focus on biologic products- are no longer conducting much of their own research and development in-house. Fewer still are capable of scaling up from laboratory to commercial production without some type of outside help from a contract manufacturing organization (CMO).    Read this article and other articles in

BioPharm International

's 2015

eBook.